AMAP-102

N/A

Report date: 2022/06/20 14:16:32
NME

Base Information

Drug NameAMAP-102
Drug Alias NameAMAP-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2b (5-HT2b) receptor agonistsSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2b (5-HT2b) receptorSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnamar AbAcurepharma
China Registration ClassN/A

Develop Information

Active CompaniesAnamar Ab
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A